Comparison of the action of putative endogenous κ-agonists, leumorphin and rimorphin in vitro
- 31 December 1983
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 33, 275-278
- https://doi.org/10.1016/0024-3205(83)90496-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A novel opioid peptide, leumorphin, acts as an agonist at the κ opiate receptorLife Sciences, 1983
- Rimorphin (dynorphin B) exists together with α-neo-endorphin and dynorphin (dynorphin A) in human hypothalamusBiochemical and Biophysical Research Communications, 1983
- A specific radioimmunoassay for the opioid peptide dynorphin B in neural tissuesNeuropeptides, 1982
- Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptorNature, 1982
- Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursorNature, 1982
- The choice of opiate receptor subtype by neo-endorphinsEuropean Journal of Pharmacology, 1982
- Dynorphin Is a Specific Endogenous Ligand of the κ Opioid ReceptorScience, 1982
- Rabbit vas deferens: A specific bioassay for opioid κ-receptor agonistsEuropean Journal of Pharmacology, 1981
- KINETIC PARAMETERS OF NARCOTIC AGONISTS AND ANTAGONISTS, WITH PARTICULAR REFERENCE TO N‐ALLYLNOROXYMORPHONE (NALOXONE)British Journal of Pharmacology and Chemotherapy, 1968